BioSpace News Archive

Emergex Vaccines Holding Limited announced that it has signed a contract with the UK Department of Health and Social Care for £1,798,109 to advance a CD8 T cell-based vaccine candidate against Chikungunya virus.

Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter, announces that it will be presenting to investors at the Florida Capital Event Conference, organized by Capital Event Management Ltd. and being hosted at the JW Marriott Turnberry, in Aventura, Florida, November 17 to 19, 2023.

AstraZeneca’s TRUQAP™ (capivasertib) in combination with fulvestrant has been approved in the US for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative locally advanced or metastatic breast cancer with one or more biomarker alterations (PIK3CA, AKT1 or PTEN).

Tharimmune, Inc. announced today that it will effect a 1-for-25 reverse stock split of its issued and outstanding shares of common stock.

Exact Sciences Corp. today announced that it has filed a lawsuit against Geneoscopy, Inc. in the United States District Court for the District of Delaware.

Humacyte today announced the presentation of positive V005 Phase 2/3 clinical trial results of the investigational Human Acellular Vessel (HAV) in the treatment of vascular trauma, as well as results from the treatment of wartime injuries in Ukraine.

Twist Bioscience Corporation today reported financial results and business highlights for the fourth quarter and full year fiscal 2023 ended September 30, 2023.

Serina Therapeutics, Inc. today announced Serina has entered into a License Agreement under which Pfizer Inc. will license, on a non-exclusive basis, Serina’s POZ polymer technology.

The Ivy Brain Tumor Center at Barrow Neurological Institute announces promising results from a Phase 0/2 trial of niraparib in patients with newly diagnosed glioblastoma with unmethylated MGMT.

Tenax Therapeutics, Inc. announced the appointment of Javed Butler, M.D., M.P.H, M.B.A., to the Company’s PH-HFpEF Scientific Advisory Board.